Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/215096 |
Resumo: | Introduction Psoriasis is an immune-mediated, chronic, inflammatory disease, which has a substantial humanistic and economic burden. This study aimed to assess the impact of this disease on health-related quality of life (HRQoL), work productivity, and direct and indirect costs from a societal perspective among Brazilian patients. Methods This is a cross-sectional, observational, multicenter study, enrolling patients with moderate to severe plaque psoriasis according to physician evaluation. Data collection was performed from December 2015 to November 2016 through face-to-face interviews using a structured questionnaire and five standardized patient-reported outcomes instruments. Direct costs were estimated by multiplying the amount of resources used (12-month recall period) by the corresponding unit cost. Indirect costs were grouped in two time horizons: annual costs (income reduction and absenteeism) and lifetime costs (demission and early retirement). Results A total of 188 patients with moderate to severe plaque psoriasis were included, with mean age of 48.0 (SD 13.1). “Anxiety and depression” and “pain and discomfort” were the most impaired dimensions, according to the EuroQol Five-Dimension-Three-Level (EQ-5D-3L). The highest effect was found for “symptoms and feelings” [mean (SD) 2.4 (1.7)] Dermatology Life Quality Index (DLQI) subscale. Psoriatic arthritis (PsA) presence and biologic-naïve status were associated with worse HRQoL. Presenteeism was more frequent than absenteeism, according to the Work Productivity and Activity Impairment questionnaire-General Health (WPAI-GH) [17.4% vs. 6.3%], while physical demands and time management were the most affected Work Limitations Questionnaire (WLQ) subscales [means (SD) 23.5 (28.5) and 17.7 (24.9), respectively]. The estimated annual cost per patient was USD 4034. Direct medical costs accounted for 87.7% of this estimate, direct non-medical costs for 2.4%, and indirect costs for 9.9%. Conclusions Results evidenced that moderate to severe plaque psoriasis imposes substantial costs to society. Our data showed that this disease negatively affects both work productivity and HRQoL of Brazilian patients. Subgroups with PsA and biologic-naïve patients presented lower HRQoL, showing the impact of this comorbidity and the relevance of biologics in psoriasis treatment. |
id |
UFRGS-2_9880e4234a8b5216af2ac07740a4cfb2 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/215096 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Lopes, NilcéiaDias, Leticia L. S.Abulafia, Luna AzulayOyafuso, Luiza Keiko MatsukaSuarez, Maria VictoriaFabrício, Lincoln Helder ZambaldiKobata, Clarice MarieCestari, Tania FerreiraGontijo, BernardoSabbag, Cid Y.Antonio, João RobertoRomiti, RicardoPertel, Patricia C.2020-11-18T04:09:40Z20190741-238Xhttp://hdl.handle.net/10183/215096001118209Introduction Psoriasis is an immune-mediated, chronic, inflammatory disease, which has a substantial humanistic and economic burden. This study aimed to assess the impact of this disease on health-related quality of life (HRQoL), work productivity, and direct and indirect costs from a societal perspective among Brazilian patients. Methods This is a cross-sectional, observational, multicenter study, enrolling patients with moderate to severe plaque psoriasis according to physician evaluation. Data collection was performed from December 2015 to November 2016 through face-to-face interviews using a structured questionnaire and five standardized patient-reported outcomes instruments. Direct costs were estimated by multiplying the amount of resources used (12-month recall period) by the corresponding unit cost. Indirect costs were grouped in two time horizons: annual costs (income reduction and absenteeism) and lifetime costs (demission and early retirement). Results A total of 188 patients with moderate to severe plaque psoriasis were included, with mean age of 48.0 (SD 13.1). “Anxiety and depression” and “pain and discomfort” were the most impaired dimensions, according to the EuroQol Five-Dimension-Three-Level (EQ-5D-3L). The highest effect was found for “symptoms and feelings” [mean (SD) 2.4 (1.7)] Dermatology Life Quality Index (DLQI) subscale. Psoriatic arthritis (PsA) presence and biologic-naïve status were associated with worse HRQoL. Presenteeism was more frequent than absenteeism, according to the Work Productivity and Activity Impairment questionnaire-General Health (WPAI-GH) [17.4% vs. 6.3%], while physical demands and time management were the most affected Work Limitations Questionnaire (WLQ) subscales [means (SD) 23.5 (28.5) and 17.7 (24.9), respectively]. The estimated annual cost per patient was USD 4034. Direct medical costs accounted for 87.7% of this estimate, direct non-medical costs for 2.4%, and indirect costs for 9.9%. Conclusions Results evidenced that moderate to severe plaque psoriasis imposes substantial costs to society. Our data showed that this disease negatively affects both work productivity and HRQoL of Brazilian patients. Subgroups with PsA and biologic-naïve patients presented lower HRQoL, showing the impact of this comorbidity and the relevance of biologics in psoriasis treatment.application/pdfengAdvances in therapy. New York. Vol. 36 (2019), p. 2849–2865PsoríaseAvaliação em saúdeEfeitos psicossociais da doençaQualidade de vidaBrasilHumanistic and economic impact of moderate to severe plaque psoriasis in BrazilEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001118209.pdf.txt001118209.pdf.txtExtracted Texttext/plain55716http://www.lume.ufrgs.br/bitstream/10183/215096/2/001118209.pdf.txt7b0f85a696f29d44654822fbf8584ebeMD52ORIGINAL001118209.pdfTexto completo (inglês)application/pdf511354http://www.lume.ufrgs.br/bitstream/10183/215096/1/001118209.pdf579b6ea0acdb7f0469a83684630f4b30MD5110183/2150962020-11-19 05:15:48.572308oai:www.lume.ufrgs.br:10183/215096Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2020-11-19T07:15:48Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
title |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
spellingShingle |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil Lopes, Nilcéia Psoríase Avaliação em saúde Efeitos psicossociais da doença Qualidade de vida Brasil |
title_short |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
title_full |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
title_fullStr |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
title_full_unstemmed |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
title_sort |
Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil |
author |
Lopes, Nilcéia |
author_facet |
Lopes, Nilcéia Dias, Leticia L. S. Abulafia, Luna Azulay Oyafuso, Luiza Keiko Matsuka Suarez, Maria Victoria Fabrício, Lincoln Helder Zambaldi Kobata, Clarice Marie Cestari, Tania Ferreira Gontijo, Bernardo Sabbag, Cid Y. Antonio, João Roberto Romiti, Ricardo Pertel, Patricia C. |
author_role |
author |
author2 |
Dias, Leticia L. S. Abulafia, Luna Azulay Oyafuso, Luiza Keiko Matsuka Suarez, Maria Victoria Fabrício, Lincoln Helder Zambaldi Kobata, Clarice Marie Cestari, Tania Ferreira Gontijo, Bernardo Sabbag, Cid Y. Antonio, João Roberto Romiti, Ricardo Pertel, Patricia C. |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Lopes, Nilcéia Dias, Leticia L. S. Abulafia, Luna Azulay Oyafuso, Luiza Keiko Matsuka Suarez, Maria Victoria Fabrício, Lincoln Helder Zambaldi Kobata, Clarice Marie Cestari, Tania Ferreira Gontijo, Bernardo Sabbag, Cid Y. Antonio, João Roberto Romiti, Ricardo Pertel, Patricia C. |
dc.subject.por.fl_str_mv |
Psoríase Avaliação em saúde Efeitos psicossociais da doença Qualidade de vida Brasil |
topic |
Psoríase Avaliação em saúde Efeitos psicossociais da doença Qualidade de vida Brasil |
description |
Introduction Psoriasis is an immune-mediated, chronic, inflammatory disease, which has a substantial humanistic and economic burden. This study aimed to assess the impact of this disease on health-related quality of life (HRQoL), work productivity, and direct and indirect costs from a societal perspective among Brazilian patients. Methods This is a cross-sectional, observational, multicenter study, enrolling patients with moderate to severe plaque psoriasis according to physician evaluation. Data collection was performed from December 2015 to November 2016 through face-to-face interviews using a structured questionnaire and five standardized patient-reported outcomes instruments. Direct costs were estimated by multiplying the amount of resources used (12-month recall period) by the corresponding unit cost. Indirect costs were grouped in two time horizons: annual costs (income reduction and absenteeism) and lifetime costs (demission and early retirement). Results A total of 188 patients with moderate to severe plaque psoriasis were included, with mean age of 48.0 (SD 13.1). “Anxiety and depression” and “pain and discomfort” were the most impaired dimensions, according to the EuroQol Five-Dimension-Three-Level (EQ-5D-3L). The highest effect was found for “symptoms and feelings” [mean (SD) 2.4 (1.7)] Dermatology Life Quality Index (DLQI) subscale. Psoriatic arthritis (PsA) presence and biologic-naïve status were associated with worse HRQoL. Presenteeism was more frequent than absenteeism, according to the Work Productivity and Activity Impairment questionnaire-General Health (WPAI-GH) [17.4% vs. 6.3%], while physical demands and time management were the most affected Work Limitations Questionnaire (WLQ) subscales [means (SD) 23.5 (28.5) and 17.7 (24.9), respectively]. The estimated annual cost per patient was USD 4034. Direct medical costs accounted for 87.7% of this estimate, direct non-medical costs for 2.4%, and indirect costs for 9.9%. Conclusions Results evidenced that moderate to severe plaque psoriasis imposes substantial costs to society. Our data showed that this disease negatively affects both work productivity and HRQoL of Brazilian patients. Subgroups with PsA and biologic-naïve patients presented lower HRQoL, showing the impact of this comorbidity and the relevance of biologics in psoriasis treatment. |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019 |
dc.date.accessioned.fl_str_mv |
2020-11-18T04:09:40Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/215096 |
dc.identifier.issn.pt_BR.fl_str_mv |
0741-238X |
dc.identifier.nrb.pt_BR.fl_str_mv |
001118209 |
identifier_str_mv |
0741-238X 001118209 |
url |
http://hdl.handle.net/10183/215096 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Advances in therapy. New York. Vol. 36 (2019), p. 2849–2865 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/215096/2/001118209.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/215096/1/001118209.pdf |
bitstream.checksum.fl_str_mv |
7b0f85a696f29d44654822fbf8584ebe 579b6ea0acdb7f0469a83684630f4b30 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817725081061687296 |